Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Ambrx Biopharma, Inc. | President and CEO, Director | Common Stock | 0 | $0 | $9.82 | Mar 7, 2024 | Direct |
Ambrx Biopharma, Inc. | President and CEO, Director | Restricted Stock Units | 0 | $0 | $9.82 | Mar 7, 2024 | Direct |
ZyVersa Therapeutics, Inc. | Director, 10%+ Owner | Common Stock | 1.38M | Dec 12, 2022 | Indirect | ||
Ambrx Biopharma Inc. | President and CEO, Director | Stock Option (right to buy) | 1.22M | Jul 5, 2023 | Direct | ||
ZyVersa Therapeutics, Inc. | Director, 10%+ Owner | Warrant (right to buy) | 177K | Dec 12, 2022 | Indirect | ||
ZyVersa Therapeutics, Inc. | Director, 10%+ Owner | Series A Convertible Preferred Stock | 1.75K | Dec 12, 2022 | Direct | ||
ZyVersa Therapeutics, Inc. | Director, 10%+ Owner | Warrant (right to buy) | 1.75K | Dec 12, 2022 | Direct | ||
SEELOS THERAPEUTICS, INC. | Director | Stock Option (right to buy) | 1.67K | Jan 4, 2024 | Direct | ||
Ambrx Biopharma, Inc. | President and CEO, Director | Option to Purchase Common Stock | 0 | Mar 7, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AMAM | Ambrx Biopharma, Inc. | Mar 7, 2024 | 5 | $0 | 4 | Mar 7, 2024 | President and CEO, Director |
SEEL | SEELOS THERAPEUTICS, INC. | Jan 4, 2024 | 1 | $0 | 4 | Jan 8, 2024 | Director |
AMAM | Ambrx Biopharma, Inc. | Dec 11, 2023 | 1 | $0 | 4 | Dec 11, 2023 | President and CEO, Director |
AMAM | Ambrx Biopharma, Inc. | Oct 27, 2023 | 1 | -$491K | 4 | Oct 31, 2023 | President and CEO, Director |
AMAM | Ambrx Biopharma Inc. | Jul 5, 2023 | 1 | $0 | 4 | Jul 7, 2023 | President and CEO, Director |
AMAM | Ambrx Biopharma Inc. | Apr 26, 2023 | 1 | $0 | 4 | Apr 28, 2023 | President and CEO, Director |
SEEL | SEELOS THERAPEUTICS, INC. | Jan 5, 2023 | 1 | $0 | 4 | Jan 5, 2023 | Director |
AMAM | Ambrx Biopharma Inc. | Jan 1, 2023 | 0 | $0 | 3 | Jan 3, 2023 | President and CEO, Director |
ZVSA | ZyVersa Therapeutics, Inc. | Dec 12, 2022 | 4 | $0 | 4 | Dec 14, 2022 | Director, 10%+ Owner |
SEEL | SEELOS THERAPEUTICS, INC. | Jun 1, 2022 | 1 | $9.79K | 4 | Jun 2, 2022 | Director |
ZVSA | Larkspur Health Acquisition Corp. | Jan 6, 2022 | 3 | $0 | 4 | Mar 10, 2022 | Chief Executive Officer, Director |
SEEL | SEELOS THERAPEUTICS, INC. | Jan 5, 2022 | 1 | $0 | 4 | Jan 6, 2022 | Director |
ZVSA | Larkspur Health Acquisition Corp. | Dec 20, 2021 | 0 | $0 | 3 | Dec 20, 2021 | Chief Executive Officer, Director |